• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: ABBOTT GERMANY ARCHITECT HAVAB-M; IGM ANTI-HAV

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

ABBOTT GERMANY ARCHITECT HAVAB-M; IGM ANTI-HAV Back to Search Results
Catalog Number 06L21-25
Device Problem Low Test Results (2458)
Patient Problem No Known Impact Or Consequence To Patient (2692)
Event Date 12/05/2017
Event Type  malfunction  
Manufacturer Narrative
An evaluation is in process.A follow-up report will be submitted when the evaluation is complete.
 
Event Description
The customer reported (b)(6) architect havab-m results on one patient.The results provided for the patient diagnosed with waldenstrom's macroglobulinemia: (b)(6).There was no additional patient information provided.There was no reported impact to patient management.
 
Manufacturer Narrative
The customer observed erratic results for a patient diagnosed with waldenstrom's macroglobulinemia.A review of tickets determined that there were no additional complaints for lot 78085li00 and no trends were identified for the complaint issue.Historical performance of architect havab-m lot 78085li00 was evaluated using world wide data from abbott link.The overall median result across all lot numbers in the field during the reviewed timeframe is 0.18 s/co.The median patient result for lot 78085li00 is 0.17 s/co and indicates that the lot is performing in line with all other reagent lots.Manufacturing documentation for lot 78085li00 was reviewed and no contributing factors to the complaint could be identified.A review of labeling concluded that the issue is sufficiently addressed.Patients suffering from waldenstrom's macroglobulinemia show increased levels of monoclonal immunugobulins (usually igm) in the serum.Waldenstrom's macroglobulinemia belongs to the group of non-hodgkin's lymphomas and the architect havab-m reagent package insert states that specimens from individuals with non-hodgkin's lymphoma may cross-react with this assay.Based on the investigation no product deficiency was identified for architect havab-m, lot 78085li00.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
ARCHITECT HAVAB-M
Type of Device
IGM ANTI-HAV
Manufacturer (Section D)
ABBOTT GERMANY
max-planck-ring 2
wiesbaden 65205
GM  65205
MDR Report Key7150850
MDR Text Key96368781
Report Number3002809144-2017-00170
Device Sequence Number1
Product Code LOL
UDI-Device Identifier00380740011093
UDI-Public00380740011093
Combination Product (y/n)N
PMA/PMN Number
K063329
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type health professional
Type of Report Initial,Followup
Report Date 03/14/2018
1 Device was Involved in the Event
1 Patient was Involved in the Event
Date FDA Received12/28/2017
Is this an Adverse Event Report? No
Is this a Product Problem Report? Yes
Device Operator Health Professional
Device Expiration Date07/31/2018
Device Catalogue Number06L21-25
Device Lot Number78085LI00
Date Manufacturer Received03/09/2018
Is This a Reprocessed and Reused Single-Use Device? No
Patient Sequence Number1
Treatment
ARCHITECT I2000SR ANALYZER, LIST # 03M74-02,; ARCHITECT I2000SR ANALYZER, LIST # 03M74-02,; SERIAL # (B)(4).; SERIAL # (B)(4).
-
-